Australia’s medicines regulator, the Therapeutic Goods Administration, has granted provisional approval for Pfizer’s comirnaty COVID-19 vaccine to be used as a booster shot for teens aged 16 and 17.
The dosage for this age group will be the same as for adults and the booster dose can be administered within three to four months after receiving the primary two doses, regardless of the branding of the first two doses.
